Home | Recommend Us | Contact us | Make NK your default homepage
TOP NEWS
BREAKING NEWS
HOME | ASTROLOGY | CHINESE ASTROLOGY | NUMEROLOGY | RECIPES | SELF HELP | PHOTO GALLERY | YOGA | TRAVEL | EDUCATION | PINCODES | BABY NAMES
NEWS CHANNELS
  • Kerala News
  • India News
  • World News
  • Business India
  • Sports News
  • Cricket News
  • Travel News
  • Health News
  • Technology
  • Literature News
  • Education News
  • NRI News
  • Spec. Features
Entertainment News
  • Bollywood News
  • Hollywood News
  • Malayalam Film
  • Tamil Film
  • Kannada Film
  • Telugu Film
Regional News
  • Andhra Pradesh
  • Gujarat News
  • Karnataka News
  • Maharashtra
  • Orissa News
  • Punjab News
  • Rajasthan News
  • Tamil Nadu
  • West Bengal
  • More India News
Best Of NewKerala

  • Festivals of India
  • Self Help
  • India Travel Maps
  • Temples of India
  • Kerala Info
  • Indian Dance Forms
  • Music of India
  • Bollywood Photos
  • Make Up Lessons
  • Weight Loss Tips
  • Top Destinations
  • World Travelogues

Home > News > technology-news

Alteplase effective within 4.5 hrs: ECASS 3

Kolkata, Oct 28 : On account of World Stroke Day, which falls on October 29 this year; the Indian Stroke Association joined the Stroke Associations across the world in recognizing that Alteplase is effective even if it is administered within 4.5 hours of onset of ischaemic stroke.

This recognition followed after the recommendations from the European Stroke Organisation (ESO), the American Stroke Association and the Lancet based on the key results from the European Cooperative Acute Stroke Study (ECASS 3). It was earlier believed that Alteplase would be effective only even if it was administered within 3 hours of the onset of ischaemic stroke in a patient.

ECASS 3, a randomised, double-blind, placebo-controlled trial, showed for the first time that thrombolysis with Alteplase can increase the likelihood of achieving good outcome with only minimal or no disability after an acute ischaemic stroke when administered in an extended time-window from 3 to 4.5 hours after symptom onset. This news comes shortly after The Lancet selected ECASS 3 as one of the top three papers of 2008, and Lancet editors singled out the study as their choice for paper of the year.

Writing in the 24 January 2009 issue of The Lancet, Executive Editor William Summerskill said that ECASS 3 and the other papers of the year 'embody the can-do spirit of visionary research. They extend the horizon of our understanding and add to our tools for treating important common health problems that were once believed overwhelming.'

The World Health Organization estimates that 5.7 million people in the world die each year from stroke. Among survivors, 40 pc experience moderate to severe disability and 10 pc require institutional care. For patients with an acute ischaemic stroke the only treatment currently available is Alteplase, which has to be administered within 3 hours of symptom onset according to its currently approved label.

Back home in India, according to WHO's Workshop Report on Stroke Surveillance in India by the Division of Non-Communicable Diseases by the Government of India & the Indian Council of Medical Research; there are 16,67,372 stroke attacks in India every year and 4568 stroke attacks everyday. Of this, 800-1000 people die of stroke everyday; whereas 1000-1500 people get paralysed for life after they suffer from stroke.

Dr. Subhash Kaul, President of Indian Stroke Association said; 'We are proud of the success of ECASS 3 and would like to thank everyone who participated in this landmark study on acute ischaemic stroke for having achieved this breakthrough in stroke treatment'.

'This time-window of an additional 1.5 hours is like a miracle of hope and life for a stroke victim for whom every ticking second is precious,' said Dr. M V Padma, Associate Professor, Department of Neurology, AIIMS.

The ECASS 3 trial was set up to investigate whether Alteplase can also safely extend the benefit of treatment in the 3 to 4.5 hour time window.

ECASS 3 included 821 patients in 15 European countries who were recruited by a team of investigators led by Professor Werner Hacke of the University of Heidelberg. Results were published in the New England Journal of Medicine in September 2008.

--IBNS

Post your comment

Read other technology-news stories

Visit Home Page for fresh content


 

PHOTO GALLERY
  • Bollywood Photos
  • Hollywood Photos
  • Fashion Photos
  • More Headlines:
    Three-year-old run over by water tanker
    Fighting terrorism a key focus of Manmohan-Obama summit
    Nokia to bid for Nortel assets
    Chandigarh to compile data of absentees due to swine flu
    Frustration creeps in, yet faith in Dalai Lama keeps Tibetans going
    Folk healers want 'healing touch' of acceptance to continue
    Buy Afghani almonds, pomegranates at trade fair
    Four Mujib killers to seek president's pardon
    India's all-female UN police unit inspires Liberians
    'UN knows what Copenhagen failure can entail'
    Sabarimala sells 1.2 lakh cans of prasadam daily
    Pakistan claims India supports insurgents
    Trial of Bangladesh border guard mutineers to begin Tuesday
    Dolphin killed by poachers in Patna
    Karnataka, its crisis, controversies and elections (Letter from Bangalore)
    Three MoUs to foster innovation, research and training
    India to promote tourism in Ladakh, Kargil
    Iran's Revolutionary Guards to hold military manoeuvres
    Argentine singer recovering after heart, lung transplant
    I can proudly tell my kids Big B was my first child: Vidya Balan
    Tibetan exiles to attend meet on environment
    Sikh groups write to Obama, seek justice for 1984 victims
    Twin blasts rocks Assam, five killed, 50 injured
    Don't execute Mujib killers, Amnesty tells Dhaka
    Raj Kundra shows off dancing skills at sangeet
    Himachal-born child detected with polio in Uttar Pradesh
    'Idiots' means 'I do it on my terms': Hirani
    Mexico's economy contracts 6.2 percent in third quarter
    A temple which welcomes only women
    Bihar's junior doctors resume work
    'The Twilight Saga: New Moon' earns USD 72.7 mn, breaks opening day record
    Six fold hike in Indian businessmen settling in New Zealand
    Three explosions in Assam, five killed, 50 injured
    Pak involved in 26/11: CIA
    China supports Indo-Pak talks
    We know that we are loved: Travolta tells neighbours
    My hips were not touched: Demi Moore
    Amy Winehouse's puffing after the gym
    Canada saved the India-US n-deal; it now needs to think beyond
    Diners eat out of toilet bowls at novelty restaurant chain
      Home | Recommend Us | Contact us | Make NK your default homepage
      © 2001-2008 NEWKERALA.COM. All Rights Reserved.